Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
61-75 of 4097 results
Merck and Selvita form drug discovery collaboration
By PBR Staff Writer
Merck and Selvita have partnered to discover small molecule lead candidates for several oncology indications.
Drug Research > Drug Discovery & Development > News
ProBioGen, Bio Farma sign deal to develop biosimilar Trastuzumab for cancer treatment
ProBioGen and Bio Farma signed an agreement for the development of a biosimilar Trastuzumab for cancer treatment.
Drug Research > Drug Discovery & Development > News
SRI International wins NICHD contract for preclinical development of new contraceptive products
SRI International has been awarded a Biological Testing Facility (BTF) contract of up to $40m from the Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD) to conduct preclinical development of potential new contraceptive and therapeutic products.
Drug Research > Drug Discovery & Development > News
PRA Health Sciences opens new bioanalytical laboratory in Assen, Netherlands
PRA Health Sciences (PRA) has opened a new bioanalytical laboratory in Assen, the Netherlands.
Drug Research > Drug Discovery & Development > News
Vertex, CRISPR Therapeutics form gene editing collaboration
By PBR Staff Writer
Vertex Pharmaceuticals has partnered with CRISPR Therapeutics to discover and develop gene-editing therapies for cystic fibrosis, sickle cell anemia and other genetic diseases.
Drug Research > Drug Discovery & Development > News
Auris Medical forms drug discovery collaboration with King's College London, UK
Auris Medical Holding has formed a drug discovery collaboration with King's College London, UK.
Drug Research > Drug Discovery & Development > News
Genentech advances second Nav1.7 inhibitor for pain into clinical development
Xenon Pharmaceuticals' partner Genentech, a member of the Roche Group, has advanced a second Nav1.7 inhibitor into clinical development.
Drug Research > Drug Discovery & Development > News
Athersys and Chugai end license deal on MultiStem cell therapy development in Japan
Athersys and Chugai Pharmaceutical have ended the license agreement between them for the exclusive development and commercialization of MultiStem cell therapy for ischemic stroke in Japan.
Drug Research > Drug Discovery & Development > News
UK and six pharmaceutical firms launch $100m dementia research fund
By PBR Staff Writer
The UK Government and six pharmaceutical companies have partnered to support a $100m fund that will support research to find out new dementia treatments.
Drug Research > Drug Discovery & Development > News
Luc Therapeutics signs deal with Novartis to accelerate NR2B NAM program
By PBR Staff Writer
Luc Therapeutics has signed a license and collaboration agreement with Novartis to accelerate development of its program for the treatment of depression.
Drug Research > Drug Discovery & Development > News
Pharmalink raises funds to advance Nefecon development to treat kidney disease
By PBR Staff Writer
Pharmalink has raised SEK100m (€10.5m) to advance the development of Nefecon as a new treatment for kidney disease.
Drug Research > Drug Discovery & Development > News
Neon Therapeutics secures $55m to develop neoantigen-based cancer immunotherapies
By PBR Staff Writer
Immuno-oncology firm Neon Therapeutics has secured $55m in initial funding to develop neoantigen-based cancer immunotherapies.
Drug Research > Drug Discovery & Development > News
Biohaven and FCCDC form alliance in early stage drug discovery research
Portage Biotech and Biohaven Pharmaceutical have formed a strategic alliance with ALS Biopharma and Fox Chase Chemical Diversity Center (FCCDC) to develop Biohaven's family of over 300 prodrugs of glutamate modulating agents as well as other innovative technologies.
Drug Research > Drug Discovery & Development > News
Daiichi Sankyo expands TaNeDS collaborative drug discovery program in Europe
Daiichi Sankyo Company announced details of the application for its Take a New Challenge for Drug Discovery (TaNeDS) Europe 2015/2016, a collaborative drug discovery initiative for universities and research institutes in Europe.
Drug Research > Drug Discovery & Development > News
Genzyme opts into Alnylam's ALN-AT3 hemophilia program
By PBR Staff Writer
Genzyme has joined in Alnylam Pharmaceuticals' investigational ALN-AT3 hemophilia program for development and commercialization in territories outside of North America and Western Europe.
Drug Research > Drug Discovery & Development > News
61-75 of 4097 results